Rachel King
Board Member
Fulcrum Therapeutics, Inc. (FULC)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Rachel King
Rachel King is recorded as Board Member at Fulcrum Therapeutics, Inc. (FULC). Fulcrum Therapeutics, Inc. reported in an 8-K filed November 12, 2024 that Rachel King was appointed member of the Board, effective November 12, 2024.
“On November 12, 2024, the Board, upon the recommendation from the Nominating and Corporate Governance Committee, appointed Rachel King as a member of the Board, with immediate effect to fill the vacancy created by Dr. Collins' resignation.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-11-12–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Fulcrum Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Alex C. Sapir CEO, Board Member
- Bryan Stuart CEO, COO, Board Member
- Robert J. Gould CEO
- Kate Haviland Chairman
- Mark Levin Chairman
- Alan A. Musso CFO
- Peter Thomson CFO
- Robert E. Gould CFO
- Mel Hayes COO
- Alan Musso Chief Accounting Officer
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.